Trials & Approvals
Ahead of FDA Review, Pfizer’s COVID Vaccine Endures See-Saw Day Including Approval in Canada
2020-12-10
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
Xofluza Garners FDA Approval for Influenza Prevention Following Contact with Infected Patients
2020-11-26